BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ruzzenente A, Valdegamberi A, Campagnaro T, Conci S, Pachera S, Iacono C, Guglielmi A. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated? World J Gastroenterol 2011; 17(46): 5083-5088 [PMID: 22171142 DOI: 10.3748/wjg.v17.i46.5083]
URL: https://www.wjgnet.com/1007-9327/full/v17/i46/5083.htm
Number Citing Articles
1
Nicolas Golse, Petru O. Bucur, René Adam, Denis Castaing, Antonio Sa Cunha, Eric Vibert. New Paradigms in Post-hepatectomy Liver FailureJournal of Gastrointestinal Surgery 2013; 17(3): 593 doi: 10.1007/s11605-012-2048-6
2
Yun-Hao Tang, Wen-Jiang Zhu, Tian-Fu Wen. Influence of Clinically Significant Portal Hypertension on Hepatectomy for Hepatocellular Carcinoma: a Meta-analysisAsian Pacific Journal of Cancer Prevention 2014; 15(4): 1649 doi: 10.7314/APJCP.2014.15.4.1649
3
Nam Hee Kim, Taeheon Lee, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolizationJournal of Gastroenterology and Hepatology 2018; 33(7): 1397 doi: 10.1111/jgh.14083
4
Jian-Hong Zhong, Hang Li, Nan Xiao, Xin-Ping Ye, Yang Ke, Yan-Yan Wang, Liang Ma, Jie Chen, Xue-Mei You, Zhi-Yuan Zhang, Shi-Dong Lu, Le-Qun Li, Devanand Sarkar. Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal HypertensionPLoS ONE 2014; 9(9): e108755 doi: 10.1371/journal.pone.0108755
5
Astrit R Hamza, Avdyl S Krasniqi, Pramod Kadaba Srinivasan, Mamdouh Afify, Christian Bleilevens, Uwe Klinge, René H Tolba. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resectionWorld Journal of Gastroenterology 2014; 20(40): 14841-14854 doi: 10.3748/wjg.v20.i40.14841
6
Jianwei Liu, Han Zhang, Yong Xia, Tian Yang, Yuzhen Gao, Jun Li, Yeye Wu, Feng Shen. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysisHPB 2019; 21(1): 1 doi: 10.1016/j.hpb.2018.07.005
7
Maria C. Russell. Complications Following HepatectomySurgical Oncology Clinics of North America 2015; 24(1): 73 doi: 10.1016/j.soc.2014.09.008
8
Simona Leoni, Fabio Piscaglia, Ilaria Serio, Eleonora Terzi, Irene Pettinari, Luca Croci, Sara Marinelli, Francesca Benevento, Rita Golfieri, Luigi Bolondi. Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology GroupDigestive and Liver Disease 2014; 46(6): 549 doi: 10.1016/j.dld.2014.02.012
9
Yang Huang, Jiulin Song, Jinli Zheng, Li Jiang, Lunan Yan, Jiayin Yang, Yong Zeng, Hong Wu. Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched AnalysisAnnals of Surgical Oncology 2020; 27(7): 2334 doi: 10.1245/s10434-020-08231-0
10
Sae Byeol Choi, Hyun Jung Kim, Tae Jin Song, Hyeong Sik Ahn, Sang Yong Choi. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysisJournal of Hepato-Biliary-Pancreatic Sciences 2014; 21(9): 639 doi: 10.1002/jhbp.124
11
Badawy A. Abdulaziz, Waleed El Agawy, Mohamed El-Tantawy Ibrahim, Medhat A. Khalil, Walid A. Abdel Halim. Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and Cholangiocarcinoma The Open Biomarkers Journal 2021; 11(1): 39 doi: 10.2174/1875318302111010039
12
Gonzalo Sapisochin, Elena Fernandez de Sevilla, Juan Echeverri, Ramón Charco. Management of “very early” hepatocellular carcinoma on cirrhotic patientsWorld Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
13
Xian-Qiang Wang, Zhe Liu, Wen-Ping Lv, Ying Luo, Guang-Yun Yang, Chong-Hui Li, Xiang-Fei Meng, Yang Liu, Ke-Sen Xu, Jia-Hong Dong. Safety validation of decision trees for hepatocellular carcinomaWorld Journal of Gastroenterology 2015; 21(31): 9394-9402 doi: 10.3748/wjg.v21.i31.9394
14
Qiang-Bo Zhang, Xiu-Guo Zhang, Run-de Jiang, Chun-Xiao Hu, Dong Sun, Lin Ran, Zong-Li Zhang. Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patientsInternational Journal of Hyperthermia 2017; 33(3): 255 doi: 10.1080/02656736.2016.1257824
15
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelularRevista de Gastroenterología de México 2014; 79(4): 250 doi: 10.1016/j.rgmx.2014.09.004
16
Mark Pines. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tractWorld Journal of Gastroenterology 2014; 20(40): 14778-14786 doi: 10.3748/wjg.v20.i40.14778
17
Wei He, Qingli Zeng, Yun Zheng, Meixian Chen, Jingxian Shen, Jiliang Qiu, Miao Chen, Ruhai Zou, Yadi Liao, Qijiong Li, Xianqiu Wu, Binkui Li, Yunfei Yuan. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysisBMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1280-3
18
R. Santambrogio, J. Salceda, M. Costa, M.D. Kluger, M. Barabino, A. Laurent, E. Opocher, D. Azoulay, D. Cherqui. External validation of a simplified BCLC staging system for early hepatocellular carcinomaEuropean Journal of Surgical Oncology (EJSO) 2013; 39(8): 850 doi: 10.1016/j.ejso.2013.05.001
19
Xiao-Pei Li, Ying Liu, Chun-Qing Zhang. Correlation Between NAT2 Gene Polymorphism and Cirrhotic Portal Hypertension in the Chinese PopulationGenetic Testing and Molecular Biomarkers 2015; 19(3): 138 doi: 10.1089/gtmb.2014.0283
20
Ferenc Jakab. Sebészi kockázat májbetegekenMagyar Sebészet 2013; 66(3): 127 doi: 10.1556/maseb.66.2013.3.1
21
Hazem M. Zakaria, Emad H. Gad, Ali Nada, Anwar A. Abdelaleem, Doha Maher, Mohammad E. Abdel Samea, Alyaa Sabry. Hepatic resection for hepatocellular carcinoma in cirrhotic patients with portal hypertensionSurgical Practice 2016; 20(4): 149 doi: 10.1111/1744-1633.12215
22
Masaaki Hidaka, Susumu Eguchi, Takanobu Hara, Akihiko Soyama, Satomi Okada, Takashi Hamada, Shinichiro Ono, Tomohiko Adachi, Kengo Kanetaka, Mitsuhisa Takatsuki. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured ValuesJournal of Investigative Surgery 2020; 33(2): 118 doi: 10.1080/08941939.2018.1476631
23
Emil Iskandarov, Pramod Kadaba Srinivasan, Wang Xin, Christian Bleilevens, Mamdouh Afify, Astrit Hamza, Lai Wei, Koichiro Hata, Boyukkishi Agayev, Rene Tolba. Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection ModelHepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.36821
24
Kosuke Kobayashi, Emilie Uldry, Takashi Kokudo, Alessandra Cristaudi, Yoshikuni Kawaguchi, Chikara Shirata, Takamune Yamaguchi, Olivier Dormond, Rafael Duran, Kiyoshi Hasegawa, Nicolas Demartines, Nermin Halkic. Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective StudyWorld Journal of Surgery 2021; 45(8): 2546 doi: 10.1007/s00268-021-06111-6
25
Annalisa Berzigotti, Maria Reig, Juan G. Abraldes, Jaime Bosch, Jordi Bruix. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysisHepatology 2015; 61(2): 526 doi: 10.1002/hep.27431
26
Tianfu Wen, Chuan Li, Lei Li. Operative Techniques in Liver Resection2016; : 13 doi: 10.1007/978-94-017-7411-6_3
27
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinomaBBA Clinical 2016; 6: 125 doi: 10.1016/j.bbacli.2016.10.001
28
Roberto Santambrogio, Michael D. Kluger, Mara Costa, Andrea Belli, Matteo Barabino, Alexis Laurent, Enrico Opocher, Daniel Azoulay, Daniel Cherqui. Hepatic resection for hepatocellular carcinoma in patients with Child–Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?HPB 2013; 15(1): 78 doi: 10.1111/j.1477-2574.2012.00594.x
29
María Reig, Annalisa Berzigotti, Jordi Bruix. If portal hypertension predicts outcome in cirrhosis, why should this not be the case after surgical resection?Liver International 2013; 33(10): 1454 doi: 10.1111/liv.12273
30
D. Bettinger, E. Knüppel, W. Euringer, H. C. Spangenberg, M. Rössle, R. Thimme, M. Schultheiß. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinomaAlimentary Pharmacology & Therapeutics 2015; 41(1): 126 doi: 10.1111/apt.12994
31
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Mexican consensus on the diagnosis and management of hepatocellular carcinomaRevista de Gastroenterología de México (English Edition) 2014; 79(4): 250 doi: 10.1016/j.rgmxen.2014.12.002